An organization of physicians and others concerned about the politicization of healthcare is praising the “doctors around the world” who are “speaking up” about the “significant” risks associated with childhood medical gender transition and the lack of evidence supporting the claim that transgender hormone drugs reduce suicide risk.
Dr. Stanley Goldfarb, chairman of Do No Harm wrote Monday in an email to subscribers of the recent “game-changing” letter to the editors, published in the Wall Street Journal by 21 clinicians and researchers from South Africa, the UK, Sweden, Norway, Belgium, France, Switzerland, and the United States, that challenges the Endocrine Society’s latest statements on what radical transgender activists call “gender-affirming care.”
Read More